Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 5/20 | 0.42 |
| ▸ | DRD3 | P35462 | 4/20 | 0.42 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.42 |
| ▸ | OPRK1 | P41145 | 3/20 | 0.42 |
| ▸ | CHRM2 | P08172 | 3/20 | 0.42 |
| ▸ | HTR1A | P08908 | 3/20 | 0.42 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.42 |
| ▸ | ADRA1A | P35348 | 3/20 | 0.42 |
| ▸ | DRD2 | P14416 | 2/20 | 0.42 |
| ▸ | ADRA2B | P18089 | 2/20 | 0.42 |
| ▸ | ADRA2C | P18825 | 2/20 | 0.42 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.42 |
| ▸ | HTR2A | P28223 | 2/20 | 0.42 |
| ▸ | HTR2C | P28335 | 2/20 | 0.42 |
| ▸ | HRH1 | P35367 | 2/20 | 0.42 |
| ▸ | HTR2B | P41595 | 2/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | DRD4 | P21917 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oxalic Acid SCHEMBL28012360 | 0.94 | CYP2D6 (0.42) | OPRM1DRD3KCNH2OPRK1CHRM2 | |
| SCHEMBL4701 | 0.91 | CHRM2 (0.48) | OPRM1DRD3KCNH2OPRK1CHRM2 | |
| Fumaric Acid SCHEMBL2118137 | 0.91 | CYP2D6 (0.40) | OPRM1DRD3KCNH2OPRK1CHRM2 | |
| Cyclohexane SCHEMBL28903496 | 0.90 | CHRM2 (0.45) | OPRM1DRD3KCNH2OPRK1CHRM2 | |
| Hydrochloric Acid SCHEMBL41905 | 0.90 | LMNA (0.49) | OPRM1DRD3KCNH2OPRK1CHRM2 | |
| Hydrochloric Acid SCHEMBL28987388 | 0.90 | LMNA (0.49) | OPRM1DRD3KCNH2OPRK1CHRM2 | |
| Sulfuric Acid SCHEMBL11655559 | 0.89 | CYP2D6 (0.42) | OPRM1DRD3KCNH2OPRK1CHRM2 | |
| SCHEMBL29045196 | 0.82 | LMNA (0.37) | OPRM1DRD3KCNH2OPRK1CHRM2 | |
| SCHEMBL19759877 | 0.75 | ALDH1A1 (0.33) | ALDH1A1PTGS1SMN1; SMN2PPARGMAOA | |
| Promethazine SCHEMBL599319 | 0.72 | CYP2D6 (0.78) | OPRM1DRD3KCNH2OPRK1CHRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 202 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160128944-A1 | COATED PARTICLES AND COMPOSITIONS COMPRISING SAME | VYOME THERAPEUTICS LIMITED (IN) | 2016-05-12 | — | — | US | claimed |
| EP-3003031-A1 | COATED PARTICLES AND COMPOSITIONS COMPRISING SAME | Vyome Biosciences Pvt Ltd (IN) | 2016-04-13 | — | — | EP | claimed |
| WO-2014195872-A1 | COATED PARTICLES AND COMPOSITIONS COMPRISING SAME | VYOME BIOSCIENCES PVT. LTD. (IN) | 2014-12-11 | — | — | WO | claimed |
| US-20140248270-A1 | METHOD FOR TOPICAL TREATMENT OF TAR-RESPONSIVE DERMATOLOGICAL DISORDERS | YU RUEY J (US) | 2014-09-04 | — | — | US | claimed |
| EP-2723452-A2 | CONJUGATE-BASED ANTIFUNGAL AND ANTIBACTERIAL PRODRUGS | Vyome Biosciences Pvt Ltd (IN) | 2014-04-30 | — | — | EP | claimed |
| WO-2012177986-A2 | CONJUGATE-BASED ANTIFUNGAL AND ANTIBACTERIAL PRODRUGS | VYOME BIOSCIENCES (IN) | 2012-12-27 | — | — | WO | claimed |
| US-20120040920-A1 | OLIGOSACCHARIDE ALDONIC ACIDS AND THEIR TOPICAL USE | YU RUEY J (US) | 2012-02-16 | — | — | US | claimed |
| US-20110091403-A1 | OLIGOSACCHARIDE ALDONIC ACIDS AND THEIR TOPICAL USE | YU RUEY J | 2011-04-21 | — | — | US | claimed |
| US-20100247463-A1 | N-(PHOSPHONOALKYL)-AMINO ACIDS, DERIVATIVES THEREOF AND COMPOSITIONS AND METHODS OF USE | YU RUEY J | 2010-09-30 | — | — | US | claimed |
| US-7776844-B2 | N-(phosphonoalkyl)-amino acids, derivatives thereof and compositions and methods of use | YU RUEY J | 2010-08-17 | — | — | US | claimed |
| US-20040033963-A1 | Urea composition | YU RUEY J (US) | 2004-02-19 | — | — | US | claimed |
| WO-2004010968-A1 | NON-AMPHOTERIC GLUTATHIONE DERIVATIVE COMPOSITIONS FOR TOPICAL APPLICATION | YU RUEY J (US) | 2004-02-05 | — | — | WO | claimed |
| US-20030229141-A1 | N-acetyl cysteine and its topical use | YU RUEY J (US) | 2003-12-11 | — | — | US | claimed |
| WO-2003086291-A2 | UREA COMPOSITIONS | YU RUEY J (US) | 2003-10-23 | — | — | WO | claimed |
| US-20030108496-A1 | Compositions comprising phenyl-glycine derivatives | YU RUEY J (US) | 2003-06-12 | — | — | US | claimed |
| WO-2003045338-A1 | COMPOSITIONS COMPRISING PHENYL-GLYCINE DERIVATIVES | YU RUEY J (US) | 2003-06-05 | — | — | WO | claimed |
| EP-1227820-A2 | OLIGOSACCHARIDE ALDONIC ACIDS AND THEIR TOPICAL USE | Yu, Ruey J., Dr. (US) | 2002-08-07 | — | — | EP | claimed |
| US-20020028227-A1 | Oligosaccharide aldonic acids and their topical use | YU RUEY J (US) | 2002-03-07 | — | — | US | claimed |
| US-6335023-B1 | VEHICLES AND OLIGOSACCHARIDE ALDONIC ACIDS | YU RUEY J (US) | 2002-01-01 | — | — | US | claimed |
| WO-2001001932-A2 | OLIGOSACCHARIDE ALDONIC ACIDS AND THEIR TOPICAL USE | YU RUEY J (US) | 2001-01-11 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110091403-A1 | OLIGOSACCHARIDE ALDONIC ACIDS AND THEIR TOPICAL USE | GLA, ALDOA, FUT6 | OPRM1 3705/4885DRD3 3995/4885KCNH2 2527/4885 |
| US-20030108496-A1 | Compositions comprising phenyl-glycine derivatives | GRHPR, ARL1, SUCLG1 | OPRM1 3737/4885DRD3 646/4885KCNH2 1228/4885 |
| US-20020028227-A1 | Oligosaccharide aldonic acids and their topical use | GLA, ALDOA, MAN2A1 | OPRM1 3306/4885DRD3 3991/4885KCNH2 2428/4885 |
| US-20120040920-A1 | OLIGOSACCHARIDE ALDONIC ACIDS AND THEIR TOPICAL USE | GLA, ALDOA, FUT6 | OPRM1 3705/4885DRD3 3995/4885KCNH2 2527/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.